Quarterly Result5 Nov 2026, 01:37 pm
Suven Life Sciences Declares Un-audited Q2 FY27 Results
AI Summary
Suven Life Sciences Ltd announced its un-audited financial results for the quarter and half year ended September 30, 2026. The Board of Directors approved the standalone and consolidated results along with the statutory auditors' limited review reports. The board meeting, which commenced at 12:00 Noon (IST) and concluded at 1:15 PM (IST), also saw the review of these financial statements. Further updates on patents are available on the company's website.
Key Highlights
- Board approved un-audited standalone and consolidated financial results.
- Results are for the quarter and half year ended September 30, 2026.
- Statutory auditors provided limited review reports.
- Board meeting concluded after reviewing financial statements.
Price Impact
More from SUVEN